Top

Published in:

01-02-2022 | Stress Incontinence | Original Article

Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis

Authors: Nobuo Okui, Hironari Miyazaki, Wataru Takahashi, Toshihide Miyauchi, Chikako Ito, Machiko Okui, Kaori Shigemori, Yoshiharu Miyazaki, Zdenko Vizintin, Matjaž Lukac

Published in: Lasers in Medical Science | Issue 1/2022

Abstract

Stress urinary incontinence (SUI) occurs when abdominal pressure, such as from coughing or sneezing, causes urine leakage. We retrospectively compared tension-free vaginal tape (TVT) and non-ablative vaginal Erbium:YAG laser treatment (VEL) by propensity score (PS) analysis in women with SUI. No PS analysis studies have investigated urethral sling surgery using polypropylene TVT and VEL for SUI. Data from patients aged 35–50 years who were treated for SUI and registered at several institutions were selected. Patients with medical records covering 1 year for the 1-h pad test, who completed the International Consultation on Incontinence Questionnaire-Short Form (ICIQ-SF) and the Overactive Bladder Symptom Score (OABSS), were included. We analyzed 102, 113, and 112 patients in the TVT, VEL, and control groups, respectively. Compared with the control group, the TVT and VEL groups exhibited significant improvement in the 1-h pad test and ICIQ-SF. In the PS analysis, the TVT and VEL groups similarly improved in the 1-h pad test and ICIQ-SF. As for the OABSS, the VEL group showed significantly greater improvement than the TVT group. In the odds ratio analysis for the 1-h pad test, no differences in any of the parameters were observed between TVT and VEL. VEL may be considered an alternative to TVT for SUI treatment.

Available only for authorised users

Abrams P, Cardozo L, Fall M, Griffiths D, Rosier P, Ulmsten U, Van Kerrebroeck P, Victor A, Wein A, Standardisation Sub-Committee of the International Continence Society (2002) The standardisation of terminology of lower urinary tract function: Report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn 21:167–178. https://doi.org/10.1002/nau.10052CrossRefPubMed

Hunskaar S, Burgio K, Diokno A, Herzog AR, Hjälmås K, Lapitan MC (2003) Epidemiology and natural history of urinary incontinence in women. Urology 62(Suppl 4A):16–23CrossRef

Heneghan C, Aronson JK, Goldacre B, Mahtani KR, Plüddemann A, Onakpoya I (2017) Transvaginal mesh failure: Lessons for regulation of implantable devices. BMJ 359:j5515CrossRef

Franić D, Fistonić I (2019) Laser therapy in the treatment of female urinary incontinence and genitourinary syndrome of menopause: An update. Biomed Res Int 2019:1576359. https://doi.org/10.1155/2019/1576359CrossRefPubMedPubMedCentral

Vizintin Z, Lukac M, Kazic M, Tettamanti M (2015) Erbium laser in gynecology. Climacteric 18:4–8. https://doi.org/10.3109/13697137.2015.1078668CrossRefPubMed

Mitsuyuki M, Štok U, Hreljac I, Yoda K, Vižintin Z (2020) Treating vaginal laxity using nonablative Er:YAG laser: A retrospective case series of patients from 2.5 years of clinical practice. Sex Med 8:265–273. https://doi.org/10.1016/j.esxm.2020.01.001CrossRefPubMedPubMedCentral

Dams SD, de Liefde-van Beest M, Nuijs AM, Oomens CW, Baaijens FP (2010) Pulsed heat shocks enhance procollagen type I and procollagen type III expression in human dermal fibroblasts. Skin Res Technol 16:354–364. https://doi.org/10.1111/j.1600-0846.2010.00441.xCrossRefPubMed

Tien YW, Hsiao SM, Lee CN, Lin HH (2017) Effects of laser procedure for female urodynamic stress incontinence on pad weight, urodynamics, and sexual function. Int Urogynecol J 28:469–476. https://doi.org/10.1007/s00192-016-3129-yCrossRefPubMed

Lin YH, Hsieh WC, Huang L, Liang CC (2017) Effect of non-ablative laser treatment on overactive bladder symptoms, urinary incontinence and sexual function in women with urodynamic stress incontinence. Taiwan J Obstet Gynecol 56:815–820. https://doi.org/10.1016/j.tjog.2017.10.020CrossRefPubMed

10.

Okui N (2019) Comparison between erbium-doped yttrium aluminum garnet laser therapy and sling procedures in the treatment of stress and mixed urinary incontinence. World J Urol 37:885–889. https://doi.org/10.1007/s00345-018-2445-xCrossRefPubMed

11.

Hara M, Sakata Y, Nakatani D, Suna S, Usami M, Matsumoto S, Sugitani T, Nishino M, Sato H, Kitamura T, Nanto S, Hamasaki T, Hori M, Komuro I, OACIS Investigators (2014) Comparison of 5-year survival after acute myocardial infarction using angiotensin-converting enzyme inhibitor versus angiotensin II receptor blocker. Am J Cardiol 114:1–8. https://doi.org/10.1016/j.amjcard.2014.03.055CrossRefPubMed

12.

Phillips C, Hillard T, Salvatore S, Toozs-Hobson P, Cardozo L (2020 Aug) Lasers in gynaecology. Eur J Obstet Gynecol Reprod Biol 251:146–155. https://doi.org/10.1016/j.ejogrb.2020.03.034.)CrossRefPubMed

13.

Shobeiri SA, Kerkhof MH, Minassian VA, Bazi T, IUGA Research and Development Committee (2019) IUGA committee opinion: Laser-based vaginal devices for treatment of stress urinary incontinence, genitourinary syndrome of menopause, and vaginal laxity. Int Urogynecol J 30(3):371–376. https://doi.org/10.1007/s00192-018-3830-0CrossRefPubMed

14.

Robinson D, Flint R, Veit-Rubin N, Araklitis G, Cardozo L (2020) Is there enough evidence to justify the use of laser and other thermal therapies in female lower urinary tract dysfunction? Report from the ICI-RS 2019. Neurourol Urodyn 39(Suppl 3):S140–S147. https://doi.org/10.1002/nau.24298CrossRefPubMed

15.

Guo JZ, Souders C, McClelland L, Anger JT, Scott VCS, Eilber KS, Ackerman AL (2020) Vaginal laser treatment of genitourinary syndrome of menopause: Does the evidence support the FDA safety communication? Menopause 27(10):1177–1184. https://doi.org/10.1097/GME.0000000000001577CrossRefPubMed

16.

Gambacciani M, Cervigni M, Gaspar A, Novakov Mikić A, Gaviria J, Koron N, Vizintin Z (2020) Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years. Climacteric 23(sup1):S28–S32. https://doi.org/10.1080/13697137.2020.1813098CrossRefPubMed

17.

Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN, International Urogynecological Association; International Continence Society (2010) An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn 29:4–20. https://doi.org/10.1002/nau.20798CrossRefPubMed

18.

Abdel-fattah M, Barrington JW, Youssef M (2004) The standard 1-hour pad test: Does it have any value in clinical practice? Eur Urol 46:377–380. https://doi.org/10.1016/j.eururo.2004.04.018CrossRefPubMed

19.

Takahashi S, Takei M, Nishizawa O, Yamaguchi O, Kato K, Gotoh M, Yoshimura Y, Takeyama M, Hideo O, Shimada M, Yamanishi T, Yoshida M, Tomoe H, Yokoyama O, Koyama M (2013) Clinical guidelines for female lower urinary tract symptoms. The Neurogenic Bladder Society, Tokyo, pp 6–168

20.

Sako T, Inoue M, Watanabe T, Ishii A, Yokoyama T, Kumon H (2011) Impact of overactive bladder and lower urinary tract symptoms on sexual health in Japanese women. Int Urogynecol J 22:165–169. https://doi.org/10.1007/s00192-010-1250-xCrossRefPubMed

21.

Huffaker RK, Livers N, Yandell PM, Shull BL, Muir TW, Kuehl TJ, Bird ET (2010) Does body mass index impact passing voiding trial after midurethral sling procedures for stress urinary incontinence? Female Pelvic Med Reconstr Surg 16:358–361. https://doi.org/10.1097/SPV.0b013e3181ff394eCrossRefPubMed

22.

Fistonić I, Fistonić N (2018) Baseline ICIQ-UI score, body mass index, age, average birth weight, and perineometry duration as promising predictors of the short-term efficacy of Er:YAG laser treatment in stress urinary incontinent women: A prospective cohort study. Lasers Surg Med. https://doi.org/10.1002/lsm.22789 Online ahead of print

23.

Tsui A, Kuh D, Cardozo L, Davis D (2018) Vascular risk factors for male and female urgency urinary incontinence at age 68 years from a British birth cohort study. BJU Int 122:118–125. https://doi.org/10.1111/bju.14137CrossRefPubMedPubMedCentral

24.

Kokanali MK, Doğanay M, Aksakal O, Cavkaytar S, Topçu HO, Özer İ (2014) Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence. Eur J Obstet Gynecol Reprod Biol 177:146–150. https://doi.org/10.1016/j.ejogrb.2014.03.039CrossRefPubMed

25.

Tamer EC, Inan D, Mut A (2020) Predictive factors for the efficacy of Er:YAG laser treatment of urinary incontinence. Maturitas 132:1–6. https://doi.org/10.1016/j.maturitas.2019.11.003CrossRef

26.

Chang KM, Hsieh CH, Chiang HS, Lee TS (2014) Risk factors for urinary incontinence among women aged 60 or over with hypertension in Taiwan. Taiwan J Obstet Gynecol 53:183–186. https://doi.org/10.1016/j.tjog.2014.04.010CrossRefPubMed

27.

Austin PC (2018) Assessing the performance of the generalized propensity score for estimating the effect of quantitative or continuous exposures on binary outcomes. Stat Med 37:1874–1894. https://doi.org/10.1002/sim.7615CrossRefPubMedPubMedCentral

28.

Lleberia-Juanós J, Bataller-Sánchez E, Pubill-Soler J, Mestre-Costa M, Ribot-Luna L, Vizcaíno MA (2011) De novo urgency after tension-free vaginal tape versus transobturator tape procedure for stress urinary incontinence. Eur J Obstet Gynecol Reprod Biol 155:229–232. https://doi.org/10.1016/j.ejogrb.2010.12.026CrossRefPubMed

29.

Mackova K, Van Daele L, Geraerts I, Krofta L, Deprest J (2020) Laser therapy for urinary incontinence and pelvic organ prolapse: A systematic review. BJOG. https://doi.org/10.1111/1471-0528.16273

30.

Gambacciani M, Palacios S (2017) Laser therapy for the restoration of vaginal function. Maturitas 99:10–15. https://doi.org/10.1016/j.maturitas.2017.01.012CrossRefPubMed

31.

Okui N (2019) Efficacy and safety of non-ablative vaginal erbium:YAG laser treatment as a novel surgical treatment for overactive bladder syndrome: Comparison with anticholinergics and β3-adrenoceptor agonists. World J Urol 37:2459–2466. https://doi.org/10.1007/s00345-019-02644-7CrossRefPubMedPubMedCentral

32.

Kuszka A, Gamper M, Walser C, Kociszewski J, Viereck V (2019) Erbium:YAG laser treatment of female stress urinary incontinence: Midterm data. Int Urogynecol J 11:1–8. https://doi.org/10.1007/s00192-019-04148-9CrossRef

33.

Tamer EC, Fernandez LDC, Inan D, Makul M (2020) Er:YAG laser treatment of urinary incontinence after failed tot/tvt procedures. Eur J Obstet Gynecol Reprod Biol. https://doi.org/10.1016/j.ejogrb.2020.07.010

34.

Andersson KE, Boedtkjer DB, Forman A (2016) The link between vascular dysfunction, bladder ischemia, and aging bladder dysfunction. Ther Adv Urol 9:11–27. https://doi.org/10.1177/1756287216675778CrossRefPubMedPubMedCentral

35.

Speich JE, Tarcan T, Hashitani H, Vahabi B, McCloskey KD, Andersson KE, Wein AJ, Birder LA (2020) Are oxidative stress and ischemia significant causes of bladder damage leading to lower urinary tract dysfunction? Report from the ICI-RS 2019. Neurourol Urodyn 39 Suppl 3:S16–S22. https://doi.org/10.1002/nau.24313CrossRefPubMed

36.

Gaspar A, Silva J, Calderon A, Di Placido V, Vizintin Z (2020) Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy. Climacteric 23(sup1):S11–S13. https://doi.org/10.1080/13697137.2020.1764525CrossRefPubMed

37.

Penteado CF, Priolli DG, Priviero FBM, Claudino MA, Franco-Penteado CF, Priolli DG, Priviero FBM, Claudino MA (2019) Progression of micturition dysfunction associated with the development of heart failure in rats: Model of overactive bladder. Life Sci 226:107–116. https://doi.org/10.1016/j.lfs.2019.04.017CrossRef

38.

Okabe YT, Shimizu S, Suetake Y, Matsui-Hirai H, Hasegawa S, Takanari K, Toriyama K, Kamei Y, Yamamoto T, Mizuno M, Gotoh M (2020) Biological characterization of adipose-derived regenerative cells used for the treatment of stress urinary incontinence. Int J Urol 28:115–124. https://doi.org/10.1111/iju.14408 Online ahead of printCrossRefPubMed

39.

Cheng J, Zhao ZW, Wen JR, Wang L, Huang LW, Yang YL, Zhao FN, Xiao JY, Fang F, Wu J, Miao YL (2020) Status, challenges, and future prospects of stem cell therapy in pelvic floor disorders. World J Clin Cases 8:1400–1413. https://doi.org/10.12998/wjcc.v8.i8.1400CrossRefPubMedPubMedCentral

40.

Peyronnet B, Greenwell T, Gray G, Khavari R, Thiruchelvam N, Capon G, Ockrim J, Lopez-Fando L, Gilleran J, Fournier G, Van Koeveringe GA, Van Der Aa F (2020) Current use of the artificial urinary sphincter in adult females. Curr Urol Rep 21:53. https://doi.org/10.1007/s11934-020-01001-1CrossRefPubMed

41.

Hagen S, Bugge C, Dean SG, Elders A, Hay-Smith J, Kilonzo M, McClurg D, Abdel-Fattah M, Agur W, Andreis F, Booth J, Dimitrova M, Gillespie N, Glazener C, Grant A, Guerrero KL, Henderson L, Kovandzic M, McDonald A, Norrie J, Sergenson N, Stratton S, Taylor A, Williams LR (2020) Basic versus biofeedback-mediated intensive pelvic floor muscle training for women with urinary incontinence: The OPAL RCT. Health Technol Assess 24:1–144. https://doi.org/10.3310/hta24700CrossRefPubMedPubMedCentral

42.

Hagen S, Elders A, Stratton S, Sergenson N, Bugge C, Dean S, Hay-Smith J, Kilonzo M, Dimitrova M, Abdel-Fattah M, Agur W, Booth J, Glazener C, Guerrero K, McDonald A, Norrie J, Williams LR, McClurg D (2020) Effectiveness of pelvic floor muscle training with and without electromyographic biofeedback for urinary incontinence in women: Multicentre randomised controlled trial. BMJ 371:m3719. https://doi.org/10.1136/bmj.m3719CrossRefPubMedPubMedCentral

43.

Pollack LM, Olsen MA, Gehlert SJ, Chang SH, Lowder JL (2020) Racial/ethnic disparities/differences in hysterectomy route in women likely eligible for minimally invasive surgery. J Minim Invasive Gynecol 27:1167–1177.e2. https://doi.org/10.1016/j.jmig.2019.09.003CrossRefPubMed

44.

Newman DK, Cardozo L, Sievert KD (2013) Preventing urinary incontinence in women. Curr Opin Obstet Gynecol 25:388–394. https://doi.org/10.1097/GCO.0b013e328364a35dCrossRefPubMed

Title: Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis
Authors: Nobuo Okui
Hironari Miyazaki
Wataru Takahashi
Toshihide Miyauchi
Chikako Ito
Machiko Okui
Kaori Shigemori
Yoshiharu Miyazaki
Zdenko Vizintin
Matjaž Lukac
Publication date: 01-02-2022
Publisher: Springer London
Keywords: Stress Incontinence
Overactive Bladder
Tension-Free Vaginal Tape
Laser
Published in: Lasers in Medical Science / Issue 1/2022
Print ISSN: 0268-8921
Electronic ISSN: 1435-604X
DOI: https://doi.org/10.1007/s10103-021-03317-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparison of urethral sling surgery and non-ablative vaginal Erbium:YAG laser treatment in 327 patients with stress urinary incontinence: a case-matching analysis

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2022

Photobiomodulation exerts anti-inflammatory effects on the vascular and cellular phases of experimental inflammatory models

Photobiomodulation effect of red LED (630 nm) on the free radical levels produced by pulp cells under stress conditions

The effect of low-level laser therapy on pathophysiology and locomotor recovery after traumatic spinal cord injuries: a systematic review and meta-analysis

Hemorrhoid laser procedure (HeLP) for second- and third-degree hemorrhoids: results from a long-term follow-up analysis

Monitoring of the choline/lipid ratio by 1H-MRS can be helpful for prediction and early detection of tumor response to nano-photo-thermal therapy

The efficacy of erbium-doped yttrium aluminum garnet (Er:YAG) laser in the treatment of decreased sexual sensation: a randomized, placebo-controlled trial